VulnerabilityModified
CVE-2023-38955
ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to obtain sensitive information about all managed devices, including their IP addresses and device names.
HIGH 7.5EPSS 0.60%
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (0.60%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to obtain sensitive information about all managed devices, including their IP addresses and device names.
- CVSS 3.1
- 7.5 HIGHCVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
- EPSS
- 0.60% probability · 47th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-668
- Affected
- zkteco/bioaccess ivs
- Source
- cve@mitre.org
References
- https://claroty.com/team82/disclosure-dashboard/cve-2023-38955Third Party Advisory
- https://claroty.com/team82/disclosure-dashboard/cve-2023-38955Third Party Advisory
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.